Indocyanine Green for Central Nervous System Tumors
NCT02710240
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
336
Enrollment
OTHER
Sponsor class
Conditions
Suspected Central Nervous System Tumors
Interventions
DRUG:
Indocyanine Green (ICG)
RADIATION:
Intraoperative near-infrared (NIR)
Sponsor
Abramson Cancer Center at Penn Medicine